CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: November 1, 2007
Result type: Reports
Project Number: SR0112-000
Product Line: Reimbursement Review

Generic Name: Paliperidone

Brand Name: Invega

Manufacturer: Janssen-Ortho Inc.

Therapeutic Area: Schizophrenia

Indications: Schizophrenia

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: May 28, 2008

Recommendation Type: Do not list